This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cyberonics: Growth in Medical Equipment

Stocks in this article: MDT BAX COV CYBX

Medtronics:

  • Revenue projected to increase by 1.90% this year and 3.10% next year
  • Earning estimated to be up 5.80% this year and 5.50% next year
  • TheStreet readers rate the stock A-




  • Baxter International:
  • Revenue projected to increase by 2.50% this year and 4.50% next year
  • Earnings estimated to be up 5.10% this year and 8.20% next year
  • TheStreet readers rate the stock A-




  • Covidien:
  • Revenue projected to be up 2.80% this year and 4.80% next year
  • Earnings estimated to increase by 8.30% this year and 7.70% next year
  • The readers of TheStreet rate the stock A-




  • Summary: Cyberonics has double-digit projections for both sales and earnings and a B+ balance sheet. The recent price momentum shows others are finding this stock. The readers of TheStreet rate all four stocks A- but CYBX has superior growth projections. To make sure you are not too late to the party I'd advise you to watch the 100-day moving average and the lower 14-day turtle chart if a weakness is signalled:

    At the time of publication the author had no shares of Cyberonics although it is on his watch list.

    At the time of publication the author had no shares of Cyberonics although it is on his watch list.
    2 of 2

    Check Out Our Best Services for Investors

    Action Alerts PLUS

    Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

    Product Features:
    • $2.5+ million portfolio
    • Large-cap and dividend focus
    • Intraday trade alerts from Cramer
    Quant Ratings

    Access the tool that DOMINATES the Russell 2000 and the S&P 500.

    Product Features:
    • Buy, hold, or sell recommendations for over 4,300 stocks
    • Unlimited research reports on your favorite stocks
    • A custom stock screener
    Stocks Under $10

    Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

    Product Features:
    • Model portfolio
    • Stocks trading below $10
    • Intraday trade alerts
    Try it NOW
    Try it NOW
    Try it NOW

    Check Out Our Best Services for Investors

    Dividend Stock Advisor

    Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

    Product Features:
    • Diversified model portfolio of dividend stocks
    • Updates with exact steps to take - BUY, HOLD, SELL
    Trifecta Stocks

    Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

    Product Features:
    • Model Portfolio
    • Intra Day Trade alerts
    • Access to Quant Ratings
    Options Profits

    Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

    Product Features:
    • Actionable options commentary and news
    • Real-time trading community
    Try it NOW
    Try it NOW
    Try it NOW
    To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
    Submit an article to us!

    Markets

    DOW 17,672.60 -141.38 -0.79%
    S&P 500 2,051.82 -11.33 -0.55%
    NASDAQ 4,757.8790 +7.4820 0.16%

    Partners Compare Online Brokers

    Free Reports

    Free Newsletters from TheStreet

    My Subscriptions:

    After the Bell

    Before the Bell

    Booyah! Newsletter

    Midday Bell

    TheStreet Top 10 Stories

    Winners & Losers

    Register for Newsletters
    Top Rated Stocks Top Rated Funds Top Rated ETFs